bevacizumab,cisplatin,atezolizumab,gemcitabine,pembrolizumab
roche,merck
['key,note,966', 'atezo', 'pembro', 'hcc', 'imbrave-050', 'arca ', 'arca, (-arcade)']
 #pro data at #asco23 supports that treatment toxicity does not worsen patients quality of life 1 imbrave-050- atezo-bev in resected/ablated #hcc - no signif detriment with atezo-bev
2 keynote-966 - pembro+cisgem in 1st line #abtc - similar time to det with pembro
#asco23 
HPB and NET Medical Oncologist at @Hospital_FJD. Chair of @myESMO Media and Press Affairs WG. Chair of @EORTC Hepato-Biliary TF. #BiliaryCancer #HCC #NET #PDAC